Evidence map›Paper›PMID 40001985›Full record

ArticleBiology2025

Long-Term Engraftment of Cryopreserved Human Neurons for In Vivo Disease Modeling in Neurodegenerative Disease.

David J Marmion, Peter Deng, Benjamin M Hiller, Rachel L Lewis, Lisa J Harms, David L Cameron, Jan A Nolta, Jeffrey H Kordower, Kyle D Fink, Dustin R Wakeman

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David J MarmionDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Peter DengStem Cell Program, Department of Neurology, Institute for Regenerative Cures, University of California Davis, Sacramento, CA 95817, USA.
Benjamin M HillerDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Rachel L LewisFujiFilm Cellular Dynamics Inc., Madison, WI 53711, USA.
Lisa J HarmsFujiFilm Cellular Dynamics Inc., Madison, WI 53711, USA.
David L CameronStem Cell Program, Department of Neurology, Institute for Regenerative Cures, University of California Davis, Sacramento, CA 95817, USA.
Jan A NoltaStem Cell Program, Department of Neurology, Institute for Regenerative Cures, University of California Davis, Sacramento, CA 95817, USA.
Jeffrey H KordowerDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Kyle D FinkStem Cell Program, Department of Neurology, Institute for Regenerative Cures, University of California Davis, Sacramento, CA 95817, USA.ORCID 0000-0002-0235-5038
Dustin R WakemanDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
UC Davis CTSC TL1 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility MentorshipTL1TR001861 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MEDICI, VALENTINA · 2016 to 2025
$4.7M
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's diseaseR01NS102486 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Kyle Fink, Jan A. Nolta · 2017 to 2026
$3.7M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
A Stewart's and Dake Family Gift NAHelp4HD International NANCATS NIH HHS TL1 Fellowship UL1 TR001860NCATS NIH HHS TL1 TR001861NCATS NIH HHS UL1 TR001860NIGMS NIH HHS T32 GM099608NIGMS NIH HHS T32GM099608NINDS NIH HHS 1R01NS102486NINDS NIH HHS R01 NS102486NINDS NIH HHS R24 201603716Parkinson's Disease Foundation NAThe Dickenson's Catalyst Fund NA
6 · The paper itself

Abstract

The transplantation of human neurons into the central nervous system (CNS) offers transformative opportunities for modeling neurodegenerative diseases in vivo. This study evaluated the survival, integration, and functional properties of cryopreserved forebrain GABAergic neurons (iGABAs) derived from human induced pluripotent stem cells (iPSCs) across three species used in translational research. iGABAs were stereotactically injected into the striatum of Sprague-Dawley rats, immunodeficient RNU rats, R6/2 Huntington's disease (HD) mice, wild-type controls, and Cynomolgus monkeys. Post-transplantation, long-term assessments revealed robust neuronal survival, extensive neurite outgrowth, and integration with host CNS environments. In immunodeficient rats, iGABAs innervated the neuraxis, extending from the prefrontal cortex to the midbrain, while maintaining mature neuronal phenotypes without uncontrolled proliferation. Similarly, grafts in nonhuman primates showed localized survival and stable phenotype at one month. In the neurodegenerative milieu of HD mice, iGABAs survived up to six months, projecting into the host striatum and white matter, with evidence of mutant huntingtin aggregates localized within the graft, indicating pathological protein transfer. These findings underscore the utility of cryopreserved iGABAs as a reproducible, scalable model for disease-specific CNS investigations and mechanistic studies of proteinopathic propagation. This work establishes a critical platform for studying neurodegenerative diseases and developing therapeutic interventions.

Indexed as

central nervous systemcryopreservationexperimental animal modelshuman cell transplantationimmune-deficient modelsinduced pluripotent stem cells (iPSCs)

Identifiers

PMID40001985
PMCPMC11852092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.